Best PLR Content Marketing Florida

Wednesday, 28 September 2016

Metamucil Orange Smooth Texture Sugar Free

Generic Name: psyllium (SIL ee um)

Brand Names: Fiberall, Hydrocil, Konsyl, Konsyl Orange Sugar-free, Konsyl-D, Konsyl-Orange, Laxmar, Laxmar Orange, Laxmar Sugar Free, Metamucil, Metamucil Berry Burst Smooth Texture Sugar Free, Metamucil Orange Coarse Milled Original Texture, Metamucil Orange Smooth Texture, Metamucil Orange Smooth Texture Sugar Free, Metamucil Original Texture Regular, Metamucil Pink Lemonade Smooth Texture Sugar-Free, Metamucil Unflavored Coarse Milled Original Texture, Metamucil Unflavored Smooth Texture Sugar Free, Natural Fiber Therapy, Perdiem Fiber Powder, Reguloid

What is Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Psyllium is a bulk-forming fiber laxative. Psyllium works by absorbing liquid in the intestines and swelling to create a softer, bulky stool that is easier to pass.

Psyllium is used to treat occasional constipation or bowel irregularity. Psyllium may also be used to treat diarrhea and may help lower cholesterol when used together with a diet low in cholesterol and saturated fat.

Psyllium may also be used for purposes not listed in this product guide.

What is the most important information I should know about Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Laxatives may be habit-forming if they are used too often or for too long. This can lead to damage of intestinal nerves or muscle tissues. Do not take psyllium for longer than directed on the label or prescribed by your doctor. You should not take this product if you are allergic to psyllium, or if you have trouble swallowing, a sudden change in bowel habits that lasts longer than 2 weeks, severe nausea, vomiting, or stomach pain, or if you have ever had a skin rash while taking psyllium.

Also talk with your doctor before using psyllium if you have a colostomy or ileostomy, rectal bleeding, or a blockage in your intestines.

Stop using psyllium and call your doctor at once if you have choking or trouble swallowing, severe stomach pain or cramping, nausea or vomiting, constipation that lasts longer than 7 days, rectal bleeding, or itchy skin rash. Do not take psyllium for longer than 7 days in a row unless your doctor has told you to.

What should I discuss with my healthcare provider before taking Metamucil Orange Smooth Texture Sugar Free (psyllium)?

trouble swallowing;

a sudden change in bowel habits that lasts longer than 2 weeks;

severe nausea, vomiting, or stomach pain; or

if you have ever had a skin rash while taking psyllium.

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:

a colostomy or ileostomy;

rectal bleeding; or

a blockage in your intestines.

Psyllium products may contain sugar, sodium, or artificial sweeteners. This may be of concern to you if you have diabetes, high blood pressure, or phenylketonuria (PKU). Check the product label if you have any of these conditions.

Psyllium is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether psyllium passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Take psyllium with a full glass (at least 8 ounces) of water or another liquid. Taking psyllium without enough liquid may cause it to swell in your throat and cause choking. Drinking plenty of fluids each day while you are taking psyllium will also help improve bowel regularity.

The psyllium wafer must be chewed before you swallow it.

Do not swallow psyllium powder dry. It must be mixed with liquid. Place the psyllium powder into an empty glass and add at least 8 ounces of water or other liquid such as fruit juice. Stir this mixture and drink all of it right away.

If the powder and liquid mixture is too thick, add more liquid. After drinking the entire mixture, add a little more liquid to the same glass, swirl gently and drink right away to make sure you get the entire dose of psyllium.

Psyllium may be only part of a complete program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.

It may take up to 3 days of using this medicine before your symptoms improve. For best results, keep using the medication as directed. Talk with your doctor if your symptoms do not improve after 2 or 3 days of treatment.

Do not take psyllium for longer than 7 days in a row unless your doctor has told you to. Store at room temperature away from moisture and heat.

What happens if I miss a dose?

Since psyllium is used as needed, it does not have a daily dosing schedule. Call your doctor promptly if your symptoms do not improve after using psyllium.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include nausea, vomiting, and stomach pain. Using a laxative too often or for too long may cause severe medical problems involving your intestines.

What should I avoid while taking Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Avoid taking other oral (by mouth) medications within 2 hours before or after you take psyllium. Bulk-forming laxatives can make it harder for your body to absorb other medications, possibly making them less effective.

Avoid breathing in the dust from psyllium powder when mixing. Inhaling psyllium dust may cause an allergic reaction.

If you take psyllium as part of a cholesterol-lowering treatment plan, avoid eating foods that are high in fat or cholesterol. Your treatment will not be as effective in lowering your cholesterol if you do not follow a cholesterol-lowering diet plan.

Metamucil Orange Smooth Texture Sugar Free (psyllium) side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using psyllium and call your doctor at once if you have a serious side effect such as:

choking or trouble swallowing;

severe stomach pain, cramping, nausea or vomiting;

constipation that lasts longer than 7 days;

rectal bleeding; or

itchy skin rash.

Less serious side effects may include:

bloating; or

minor change in your bowel habits.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Tell your doctor about all other medications you use, especially:

a blood thinner such as warfarin (Coumadin, Jantoven); or

demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).

This list is not complete and other drugs may interact with psyllium. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.

More Metamucil Orange Smooth Texture Sugar Free resources

Metamucil Orange Smooth Texture Sugar Free Side Effects (in more detail)
Metamucil Orange Smooth Texture Sugar Free Use in Pregnancy & Breastfeeding
Metamucil Orange Smooth Texture Sugar Free Drug Interactions
0 Reviews for Metamucil Orange Smooth Texture Sugar Free - Add your own review/rating

Konsyl Powder MedFacts Consumer Leaflet (Wolters Kluwer)

Metamucil MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Metamucil Orange Smooth Texture Sugar Free with other medications

Constipation
Dietary Fiber Supplementation
Irritable Bowel Syndrome

Where can I get more information?

Your pharmacist can provide more information about psyllium.

See also: Metamucil Orange Smooth Texture Sugar Free side effects (in more detail)

halcinonide Topical application

hal-SIN-oh-nide

Commonly used brand name(s)

In the U.S.

Halog

In Canada

Halog Cream

Halog Ointment

Halog Solution

Available Dosage Forms:

Solution

Cream

Ointment

Therapeutic Class: Corticosteroid, Strong

Pharmacologic Class: Adrenal Glucocorticoid

Uses For halcinonide

Halcinonide topical is used to help relieve redness, itching, swelling, or other discomfort caused by skin conditions. halcinonide is a corticosteroid (cortisone-like medicine or steroid).

halcinonide is available only with your doctor's prescription.

Before Using halcinonide

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For halcinonide, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to halcinonide or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of halcinonide topical in the pediatric population. However, because of halcinonide's toxicity, it should be used with caution. Children may absorb large amounts through the skin, which can cause serious side effects. If your child is using halcinonide, follow your doctor's instructions very carefully.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of halcinonide topical in the elderly.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Proper Use of halcinonide

It is very important that you use halcinonide only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so may cause unwanted side effects or skin irritation.

halcinonide is for use on the skin only. Do not get it in your eyes, nose, mouth, or vagina. Do not use it on skin areas that have cuts, scrapes, or burns. If it does get on these areas, rinse it off right away with water.

halcinonide should only be used for skin conditions that your doctor is treating. Check with your doctor before using it for other conditions, especially if you think that a skin infection may be present. halcinonide should not be used to treat certain kinds of skin infections or conditions, such as severe burns.

To use:

Wash your hands with soap and water before and after using halcinonide.

Apply a thin layer of halcinonide to the affected area of the skin. Rub it in gently.

Do not bandage or otherwise wrap the skin being treated unless directed to do so by your doctor.

If the medicine is applied to the diaper area of an infant, do not use tight-fitting diapers or plastic pants unless directed to do so by your doctor.

If your doctor ordered an occlusive dressing or airtight covering to be applied over the medicine, make sure you know how to apply it. Occlusive dressings increase the amount of medicine absorbed through your skin, so use them only as directed. If you have any questions about this, check with your doctor.

Dosing

The dose of halcinonide will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of halcinonide. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

For topical dosage forms (cream and ointment):
- For redness, itching, and swelling of the skin:
  - Adults—Apply to the affected area of the skin two to three times per day.
  - Children—Apply to the affected area of the skin two to three times per day.

Missed Dose

If you miss a dose of halcinonide, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using halcinonide

It is very important that your doctor check the progress of you or your child at regular visits for any unwanted effects that may be caused by halcinonide.

If your or your child's symptoms do not improve within a few days, or if they become worse, check with your doctor.

Using too much of halcinonide or using it for a long time may increase your risk of having adrenal gland problems. The risk is greater for children and patients who use large amounts for a long time. Talk to your doctor right away if you or your child have more than one of these symptoms while you are using halcinonide: blurred vision; dizziness or fainting; a fast, irregular, or pounding heartbeat; increased thirst or urination; irritability; or unusual tiredness or weakness.

Stop using halcinonide and check with your doctor right away if you or your child have a skin rash, burning, stinging, swelling, or irritation on the skin.

Do not use cosmetics or other skin care products on the treated areas.

halcinonide Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Incidence not known

Blistering, burning, crusting, dryness, or flaking of the skin

irritation

itching, scaling, severe redness, soreness, or swelling of the skin

redness and scaling around the mouth

thinning of the skin with easy bruising, especially when used on the face or where the skin folds together (e.g. between the fingers)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

Acne or pimples

burning and itching of the skin with pinhead-sized red blisters

burning, itching, and pain in hairy areas, or pus at the root of the hair

increased hair growth on the forehead, back, arms, and legs

lightening of normal skin color

lightening of treated areas of dark skin

reddish purple lines on the arms, face, legs, trunk, or groin

softening of the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: halcinonide Topical application side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

Compare halcinonide Topical application with other medications

Atopic Dermatitis
Dermatitis
Eczema
Psoriasis

Minoxidil topical

Class: Skin and Mucous Membrane Agents, Miscellaneous
ATC Class: C02DC01
VA Class: DE900
Chemical Name: 3-oxide 6-(1-piperidinyl)-2,4-pyrimidinediamine
Molecular Formula: C₉H₁₅N₅O
CAS Number: 38304-91-5
Brands: Hair Regrowth, Rogaine, Theroxidil

Introduction

Hair stimulant; a piperidinopyrimidine-derivative vasodilator.⁵ ¹⁹ ²⁰ ³⁷ ⁴³ ⁴⁴ ⁷³ ⁴ ⁹ ¹⁴ ¹⁵ ²⁰ ⁴⁰ ⁴³ ⁵⁶

Uses for Minoxidil

Androgenetic Alopecia

Stimulates regrowth of hair in men and women with androgenetic alopecia (male-pattern alopecia, hereditary alopecia, common male baldness).¹ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁵ ¹⁶ ²² ²³ ²⁴ ²⁵ ²⁶ ²⁷ ²⁸ ²⁹ ³⁰ ³¹ ³² ³³ ³⁴ ³⁵ ³⁶ ³⁹ ⁴⁰ ⁵⁹ ⁸³ ⁸⁵

Recommended for use in men who have general thinning of hair at the vertex of the scalp ¹¹⁵ ¹¹⁶ ¹²¹ ¹²² ¹²³ ¹²⁶ and in women who have general thinning of hair in frontoparietal areas.¹¹⁵ ¹¹⁷ May be ineffective in men or women with more extensive hair loss.¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶

Not recommended for patients without a family history of hair loss or for those with hair loss associated with childbirth, or for those who have hair loss that occurs suddenly or for unknown reasons.¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶

Generally most effective in men <40 years of age,⁵ ¹¹⁵ ¹¹⁶ ¹⁰⁰ ¹⁰¹ with <10 years duration of hair loss,⁶ ²³ ³⁹ ¹⁰⁰ ¹⁰¹ ¹¹⁵ ¹¹⁶ <10 cm diameter of baldness, ⁵ ⁶ ²³ ³⁹ ¹⁰⁰ ¹⁰¹ ¹¹⁵ ¹¹⁶ and with large number of terminal or intermediate hairs before initiation of therapy.⁵ ²³ ³⁹ ¹⁰⁰ ¹⁰¹

Alopecia Areata

Has been used to promote hair regrowth in males and females with alopecia areata†, including alopecia totalis or universalis.⁹ ⁴⁴ ⁴⁵ ⁴⁶ ⁴⁷ ⁴⁸ ⁴⁹ ⁵⁰ ⁵¹ ⁵² ⁵³

Hair Transplantation

Has been used as an adjunct to hair transplantation†; may promote better evolution of hair grafts by reducing postoperative shedding of hair and hastening the onset of postsheddng hair regrowth.⁶⁴ ⁶⁵

Minoxidil Dosage and Administration

Administration

Topical Administration

Apply topically to the scalp as a 2 or 5% solution or as a 5% foam.¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b ^c ^d

For dermatologic use only;¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ avoid contact with eyes, mucous membranes, or sensitive or abraded skin areas.¹ ⁴⁰ ⁸⁵ ¹⁰¹ (See Dermatologic Effects under Cautions.) If contact with any of these areas occurs, flush area with large amounts of cool water.¹ ⁸⁵ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³

Apply to the scalp only; do not apply to other areas of the body because of risk of systemic adverse effects.¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ (See Systemic Effects under Cautions.)

In men, apply 2 or 5% solution or 5% foam to total affected (balding and anticipated balding) areas of the scalp twice daily, usually in the morning and evening.¹ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁵ ¹⁶ ²² ²³ ²⁴ ²⁵ ²⁶ ²⁷ ²⁸ ²⁹ ³⁰ ³¹ ³² ³³ ³⁴ ³⁵ ³⁶ ³⁹ ⁴⁰ ⁵⁹ ⁸³ ¹⁰¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^c

In women, apply 2% solution to total affected areas of the scalp twice daily, usually in the morning and evening;¹¹⁷ ^d 5% solution and 5% foam should not be used in women.¹²⁶ ^b ^c

Apply solution and foam to dry scalp.¹ ⁸⁵ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b ^c ^d

To apply solution, use applicator provided by the manufacturer and apply evenly over total affected areas of the scalp.⁸⁵ ^a ^b ^d

To apply foam, part hair into ≥1 rows to expose scalp.^c Rinse hands with cold water and dry thoroughly to minimize foam melting on warm skin.^c Hold container upside down and press nozzle to dispense ½ capful of foam onto fingers; apply foam to affected areas and gently massage into scalp.^c

Wash hands thoroughly after application using fingertips.¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b ^c ^d

Dosage

Adults

Androgenetic Alopecia

Treatment in Men

Topical

Apply 1 mL of 2 or 5% solution to affected areas of the scalp twice daily.¹ ⁵ ⁶ ⁷ ⁸ ⁹ ¹⁵ ¹⁶ ²² ²³ ²⁴ ²⁵ ²⁶ ²⁷ ²⁸ ²⁹ ³⁰ ³¹ ³² ³³ ³⁴ ³⁵ ³⁶ ³⁹ ⁴⁰ ⁵⁹ ⁸³ ¹⁰¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b

Apply ½ capful of 5% foam to affected areas of the scalp twice daily.^c

≥4 months of use may be necessary before regrowth observed.¹ ⁵ ⁶ ⁷ ⁶⁷ ¹⁰¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b ^c ^d Therapy must be continued indefinitely for maintenance of hair growth.¹ ⁶ ⁷ ⁹ ²⁴ ⁴⁰ ⁶⁷ ⁸³ ¹⁰⁰ ¹⁰¹ ¹⁰⁹ ¹¹⁵ ¹¹⁶ ¹²¹ ¹²² ¹²³ ¹²⁶

Treatment in Women

Topical

Apply 1 mL of 2% solution to affected areas of the scalp twice daily.¹¹⁷ ^d

Alopecia Areata†

Topical

Apply 1 mL of 5% solution to affected areas of the scalp twice daily.⁴⁵ ⁴⁶ ⁴⁹ ⁵² ⁵³ ¹⁰⁰ ¹⁰¹

Prescribing Limits

Adults

Androgenetic Alopecia

Treatment in Men

Topical

Maximum 2 mL of 2 or 5% solution daily.¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^b ^d

Maximum ½ capful of 5% foam per application.^c

Treatment in Women

Topical

Maximum 2 mL of 2% solution daily.¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶ ^a ^d

Special Populations

No special population dosage recommendations at this time.^a ^b ^c ^d

Cautions for Minoxidil

Contraindications

Known hypersensitivity to minoxidil or any ingredient in the formulation.¹

Warnings/Precautions

General Precautions

Dermatologic Effects

Possible adverse local dermatologic effects (e.g., pruritus, dryness, scaling/flaking, local irritation or burning);¹ ⁵ ⁸ ⁹ ¹⁵ ¹⁶ ²² ²³ ²⁶ ²⁷ ²⁹ ³⁰ ³² ⁴⁰ ⁴⁶ ⁵⁶ ⁸³ ⁸⁵ ⁹⁶ may occur more frequently with the 5 than the 2% topical solution¹²⁶ and may result from alcohol contained in formulation¹ ⁸⁵ and the wearing of a wig or hairpiece.⁵³ Local irritation usually is mild¹ ⁵ ⁹ ¹⁵ ¹⁶ ²⁶ ²⁹ ³⁸ ³⁹ ⁴⁶ ⁵¹ ⁵³ ⁵⁶ ⁸³ ⁸⁵ ⁹⁶ and rarely requires discontinuance of therapy.⁴⁶ ⁵¹ ⁵⁶

If irritation occurs, flush area with large amounts of cool water; contact clinician if irritation persists.¹ ⁸⁵ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³

Increased hair growth outside area of drug application (e.g., face, beard, eyebrows, ear, arm) reported; possibly due to inadvertent transfer of drug solution.¹ ⁵ ²² ³² ⁴⁶ ⁵⁰ ⁵¹ ⁵² ⁸³

Systemic Effects

Potential systemic adverse effects (e.g., weight gain, edema, tachycardia, hypotension),¹ ⁹ ²² ³² ⁴⁰ ⁸⁶ ⁹³ ¹⁰⁰ ¹¹⁰ ¹¹¹ especially in individuals with propensity for greater percutaneous absorption or with increased sensitivity to the drug.¹ ⁹ ⁹³ ¹⁰¹ Excessive doses, local abrasion or inflammation, or severe sunburn also may increase risk of systemic effects.¹ ¹⁰¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ^a ^b ^d

Use not recommended on inflamed, erythematous, infected, irritated, or painful scalp.¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ^a ^b ^c ^d

Exposure to UV Light

Severe UV light-induced skin injury (e.g., severe sunburn) may enhance percutaneous absorption and increase risk of systemic effects.¹ ¹⁰¹ (See Systemic Effects under Cautions.)

Specific Populations

Pregnancy

Category C.^e

Lactation

Distributed into milk after oral administration;⁷² ¹¹⁵ however, not known whether topical minoxidil is distributed into milk.^d AAP classifies minoxidil as compatible with breast-feeding.^e

Pediatric Use

Safety and efficacy not established in children <18 years of age.¹

Women

Prior to initiating therapy for androgenetic alopecia, consider possibility of an underlying endocrine abnormality (e.g., polycystic ovary [Stein-Leventhal] syndrome, Cushing’s syndrome, androgen-secreting tumors, hypothyroidism).⁹ ⁸⁴ ¹⁰⁰ ¹⁰¹

Severe, diffuse hypertrichosis involving the face and limbs reported in women after 2–3 months of therapy with 5% solution for treatment of androgenetic alopecia; resolved within 4–5 months following discontinuance of therapy.¹³²

Common Adverse Effects

Pruritus, ¹ ⁵ ⁸ ⁹ ¹⁵ ¹⁶ ²² ²³ ²⁶ ²⁷ ²⁹ ³⁰ ³² ⁴⁰ ⁴⁶ ⁵⁶ ⁸³ ⁸⁵ ⁹⁶ dryness, ⁵ ²² ⁴⁰ ⁸³ scaling/flaking, ¹ ⁵ ⁹ ²⁶ ⁴⁶ ⁸³ local irritation or burning.¹ ⁵ ⁹ ¹⁵ ¹⁶ ²⁶ ²⁹ ³⁸ ³⁹ ⁴⁶ ⁵¹ ⁵³ ⁵⁶ ⁸³ ⁸⁵ ⁹⁶

Interactions for Minoxidil

Topical Preparations

Possible pharmacokinetic interaction (increased percutaneous absorption of minoxidil).¹⁰¹ ¹²⁹ ¹³⁰ Safety and efficacy of combined therapy with other topical drugs not established.¹³¹ Concomitant use with other topical drugs on the scalp is not recommended.^a ^b ^c ^d

Specific Drugs

Drug	Interaction	Comments
Hypotensive agents (guanethidine)	Possible increased risk of orthostatic hypotension if systemic absorption of minoxidil occurs¹	Use concomitantly with caution¹
Tretinoin, topical	Potential increased percutaneous absorption of minoxidil¹⁰¹ ¹²⁹ ¹³⁰	Safety and efficacy of combined use requires further evaluation¹³¹

Minoxidil Pharmacokinetics

Absorption

Bioavailability

Minimally absorbed following topical application to intact scalp;¹ ¹⁵ ¹⁶ ⁴³ ⁶¹ 1.4% of a 2% topical solution may be absorbed.⁷⁰

Onset

Onset of hair regrowth is variable; however, 2 or ≥4 months usually required before evidence of regrowth is observed following topical administration with 2 or 5% topical solutions, respectively.¹ ²³ ²⁵ ²⁷ ³⁰ ³⁴ ³⁶ ⁵⁹ ¹⁰¹ ¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ ¹²⁶

Distribution

Extent

Not fully determined following topical administration;¹⁰⁰ ¹⁰¹ however, intact stratum corneum may serve as a barrier that inhibits substantial diffusion of topically applied minoxidil into systemic circulation.⁶⁸ ⁷¹ ¹⁰¹

Not known whether topical minoxidil crosses the placenta or is distributed into milk.¹ ⁷² ^e

Elimination

Metabolism

Not fully determined following topical administration;¹ however, appears to be converted in the hair follicle to an active metabolite, minoxidil sulfate, by minoxidil sulfotransferase.¹⁷

Elimination Route

Excreted principally in urine.⁶¹

Stability

Storage

Topical

Solution

20–25°C.¹²⁶ ¹³² Keep away from heat and flame.^a ^b ^d

Foam

20–25°C.^c Keep away from heat and flame; do not puncture or incinerate container.^c

ActionsActions

Exact mechanism of action not fully elucidated; however, appears to act at the level of the hair follicle,⁴ ⁵ ⁶ ⁷ ⁹ ¹⁰ ¹⁴ ¹⁵ ¹⁶ ¹⁷ ¹⁸ ¹⁹ ²⁰ ³¹ ⁶² ⁸¹ possibly directly stimulating hair follicle epithelial growth.⁴ ⁶ ⁹ ¹⁰ ¹⁴ ¹⁵ ¹⁷ ¹⁸ ¹⁹ ²⁰ ⁸¹ ¹⁰⁰

May induce follicle hypertrophy and a return to more normal hair follicle diameter and depth in existing small follicles (i.e., regrowth) rather than stimulation of new follicle formation.⁴ ⁵ ⁶ ⁷ ⁹ ¹⁷ ¹⁹ ²⁰ ⁵⁹

Appears to prolong the anagen phase of the hair follicle, and accelerate the cyclic turnover of vellus hair follicles, enabling these follicles to produce thick, terminal hair⁴ ⁶ ⁹ ¹⁹ ²⁰ ¹⁰⁶

May directly induce proliferation of hair epithelial cells near the base of the hair follicle and increase incorporation of cysteine and glycine into the follicle;¹⁴ cysteine residues cross-link to form cystine, which provides strength to the hair shaft.⁵⁹

Advice to Patients

Product is flammable; importance of keeping product and area of application away from open flame and heat.^a ^b ^c ^d

Importance of using only as directed, only for the indicated types of hair loss, and for at least 2–4 months in order to see results; continuous use required to maintain hair regrowth.^a ^b ^c ^d (See Topical Administration under Dosage and Administration.)

Importance of applying only to healthy, normal scalp and not using topical minoxidil if scalp is inflamed, erythematous, infected, irritated, or painful.¹¹⁶ ¹¹⁷ ¹²¹ ¹²² ¹²³ Importance of avoiding contact with the eyes.^a ^b ^c ^d

Importance of washing hands after application.^a ^b ^c ^d

Importance of women using only 2% solution; 5% solution and 5% foam should not be used in women.^a ^b ^c ^d

Importance of reporting any local or systemic adverse reactions, especially chest pain, tachycardia, dizziness, unexplained weight gain, or peripheral edema, to a clinician.^a ^b ^c ^d

Importance of informing clinicians of existing or contemplated therapy, including prescription and OTC drugs and dietary or herbal supplements, as well as concomitant illnesses.^a ^b ^c ^d

Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.^a ^b ^c ^d

Importance of informing patients of other important precautionary information.^a ^b ^c ^d (See Cautions.)

Preparations

Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.

* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name

Minoxidil
Routes	Dosage Forms	Strengths	Brand Names	Manufacturer
Topical	Solution	2%*	Hair Regrowth (with alcohol 60% and propylene glycol)	Eckerd, Rite Aid
			Rogaine Hair Regrowth Treatment for Men (with alcohol 60% and propylene glycol)	Pfizer
			Rogaine Hair Regrowth Treatment for Women (with alcohol 60% and propylene glycol)	Pfizer
		5%*	Rogaine for Men Extra Strength (with alcohol 30% and propylene glycol)	Pfizer
			Theroxidil (with alcohol 30% and propylene glycol)	Harmony
	Foam	5%*	Rogaine Hair Regrowth Treatment for Men (with alcohol SD 40-B, butane, butylated hydroxytoluene, isobutane, and propane)	Pfizer

Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.

The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions November 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

References

1. The Upjohn Company. Rogaine (minoxidil topical solution) prescribing information. Kalamazoo, MI; 1990 Feb.

2. The Upjohn Company. Rogaine (minoxidil topical solution) product information. Kalamazoo, MI; 1988 Aug.

3. Dawber RPR. Aetiology and pathophysiology of hair loss. Dermatologica. 1987; 175(Suppl 2):23-8.

4. Headington JT. Hair follicle biology and topical minoxidil: possible mechanisms of action. Dermatologica. 1987; 175(Suppl 2):19-22. [PubMed 3319729]

5. Katz HI. Topical minoxidil: review of efficacy and safety. Cutis. 1989; 43:94-8. [PubMed 2644080]

6. Voorhees JJ. Editor’s summary. Dermatologica. 1987; 175(Suppl 2):54-6.

7. Katz HI. Topical minoxidil: review of efficacy. Clin Dermatol. 1988; 6:195-9. [PubMed 3063371]

8. Shupack JL, Kassimir JJ, Thirumoorthy T et al. Dose-response study of topical minoxidil in male pattern alopecia. J Am Acad Dermatol. 1987; 16:673-6. [PubMed 3549801]

9. Clissold SP, Heel RC. Topical minoxidil: preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs. 1987; 33:107-22. [IDIS 228948] [PubMed 3552591]

10. Fiedler-Weiss VC. Potential mechanisms of minoxidil-induced hair growth in alopecia areata. J Am Acad Dermatol. 1987; 16:653-6. [PubMed 3558910]

11. Bunker CB, Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet. 1987; 1:1266.

12. Bunker CB, Dowd PM. Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia. Br J Dermatol. 1987; 117:668-9. [IDIS 237238] [PubMed 3689690]

13. Fiedler-Weiss VC, Buys CM. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation. Br J Dermatol. 1987; 117:759- 63. [PubMed 3501310]

14. Buhl AE, Waldon DJ, Kawabe TT et al. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol. 1989; 92:315-20. [PubMed 2465357]

15. Fiedler VC. Minoxidil: clinical and basic research in perspective. Semin Dermatol. 1987; 6:101- 7.

16. Fiedler-Weiss VC. Minoxidil. Dermatol Clin. 1987; 5:627-35. [PubMed 3301118]

17. Uno H, Cappas A, Brigham P. Action of topical minoxidil in the bald stump-tailed macaque. J Am Acad Dermatol. 1987; 16:657-68. [PubMed 3558911]

18. Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment. Dermatologica. 1987; 175(Suppl 2):29-35. [PubMed 2961630]

19. Headington JT, Novak E. Clinical and histologic studies of male pattern baldness treated with topical minoxidil. Curr Ther Res Clin Exp. 1984; 36:1098-106.

20. Uno H, Cappas A, Schlagel C. Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques. Am J Dermatopathol. 1985; 7:283-97. [PubMed 4051135]

21. Eller MG, Szpunar GJ, Della-Coletta AA. Absorption of minoxidil after topical application: effect of frequency and site of application. Clin Pharmacol Ther. 1989; 45:396-402. [IDIS 253526] [PubMed 2702797]

22. Olsen EA, Weiner MS, Delong ER et al. Topical minoxidil in early male pattern baldness. J Am Acad Dermatol. 1985; 13:185-92. [PubMed 3900155]

23. De Villez RL. Topical minoxidil therapy in hereditary androgenetic alopecia. Arch Dermatol. 1985; 121:197-202. [IDIS 196318] [PubMed 3883902]

24. Tosti A. Topical minoxidil useful in 18% of patients with androgenetic alopecia: a study of 430 cases. Dermatologica. 1986; 173:136-8. [PubMed 3770260]

25. Storer JS, Brzuskiewicz J, Floyd H et al. Review: topical minoxidil for male pattern baldness. Am J Med Sci. 1986; 291:328-33. [IDIS 215989] [PubMed 3518451]

26. Civatte J, Laux B, Simpson NB et al. 2% topical minoxidil solution in androgenetic baldness: preliminary European results. Dermatologica. 1987; 175(Suppl 2):42-9. [PubMed 3319731]

27. Rietschel RL, Duncan SH. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol. 1987; 16:677-85. [PubMed 3549802]

28. Kreindler TG. Topical minoxidil in early androgenetic alopecia. J Am Acad Dermatol. 1987; 16:718-24. [PubMed 3549807]

29. Roberts JL. Androgenetic alopecia: treatment results with topical minoxidil. J Am Acad Dermatol. 1987; 16:705-10. [PubMed 3549805]

30. Savin RC. Use of topical minoxidil in the treatment of male pattern baldness. J Am Acad Dermatol. 1987; 16:696-704. [PubMed 3549804]

31. Katz HI, Hien NT, Prawer SE et al. Long-term efficacy of topical minoxidil in male pattern baldness. J Am Acad Dermatol. 1987; 16:711-8. [PubMed 3549806]

32. Olsen EA, DeLong ER, Weiner MS. Long-term follow-up of men with male pattern baldness treated with topical minoxidil. J Am Acad Dermatol. 1987; 16:688-95. [PubMed 3549803]

33. Olsen EA, DeLong ER, Weiner MS. Dose-response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol. 1986; 15:30-7. [PubMed 3722507]

34. De Villez RL. Androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1987; 16:669-72. [PubMed 3549800]

35. De Villez RL. Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection. Dermatologica. 1987; 175(Suppl 2):50-3.

36. Koperski JA, Orenberg EK, Wilkinson DI. Topical minoxidil therapy for androgenetic alopecia. Arch Dermatol. 1987; 123:1483-7. [IDIS 235936] [PubMed 3314717]

37. Vanderveen EE, Ellis CN, Kang S et al. Topical minoxidil for hair regrowth. J Am Acad Dermatol. 1984; 11:416-21. [PubMed 6384289]

38. Weiss VC, West DP. Topical minoxidil therapy and hair regrowth. Arch Dermatol. 1985; 121:191-2. [IDIS 196316] [PubMed 3977331]

39. Rumsfield JA, West DP, Fiedler-Weiss VC. Topical minoxidil therapy for hair regrowth. Clin Pharm. 1987; 6:386-92. [IDIS 229037] [PubMed 3311578]

40. de Groot AC, Nater JP, Herxheimer A. Minoxidil: hope for the bald? Lancet. 1987; 1:1019-21. Editorial.

41. Mitchell AD, De Villez R. Minoxidil for male- pattern baldness. Lancet. 1987; 1:1436. [PubMed 2884528]

42. de Groot AC, Nater JP, Herxheimer A. Minoxidil for male-pattern baldness. Lancet. 1987; 2:563. [PubMed 2887848]

43. Novak E, Franz TJ, Headington JT et al. Topically applied minoxidil in baldness. Int J Dermatol. 1985; 24:82-7. [PubMed 3886571]

44. Fenton DA, Wilkinson JD. Topical minoxidil in the treatment of alopecia areata. BMJ. 1983; 287:1015-7. [IDIS 177632] [PubMed 6412929]

45. Weiss VC, West DP, Fu TS et al. Alopecia areata treated with topical minoxidil. Arch Dermatol. 1984; 120:457-63. [IDIS 185288] [PubMed 6703751]

46. Price VH. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol. 1987; 16:730-6. [PubMed 3549809]

47. King CM, Harrop B, Dave VK. Topical minoxidil in the treatment of alopecia areata. BMJ. 1983; 287:1380. [IDIS 178404] [PubMed 6416428]

48. Maitland JM, Aldridge RD, Main RA et al. Topical minoxidil in the treatment of alopecia areata. BMJ. 1984; 288:794. [IDIS 183293] [PubMed 6423083]

49. Fiedler-Weiss VC, West DP, Buys CM et al. Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol. 1986; 122:180-2. [IDIS 211658] [PubMed 3947124]

50. White SI, Friedmann PS. Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol. 1985; 121:591. [IDIS 199275] [PubMed 3994404]

51. Price VH. Topical minoxidil in extensive alopecia areata, including 3-year follow-up. Dermatologica. 1987; 175(Suppl 2):36-41. [PubMed 3691913]

52. Price VH. Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. J Am Acad Dermatol. 1987; 16:737-44. [PubMed 3549810]

53. Fiedler-Weiss VC. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol. 1987; 16:745-8. [PubMed 3549811]

54. Hamilton JB. Patterned loss of hair in man: types and incidence. Ann NY Acad Sci. 1951; 53:708- 28. [PubMed 14819896]

55. Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975; 68:1359-65. [PubMed 1188424]

56. Roenigk HH Jr, Pepper E, Kuruvilla S. Topical minoxidil therapy for hereditary male pattern alopecia. Cutis. 1987; 39:337-42. [PubM

magaldrate

Generic Name: magaldrate (MAG al drate)

Brand names: Ron Acid, Riopan, Lowsium, Maoson, Ri-Mag, Losospan

What is magaldrate?

Magaldrate is an aluminum-containing antacid.

Magaldrate is used to treat heartburn, indigestion, or stomach upset.

Magaldrate may also be used for other purposes not listed in this medication guide.

What is the most important information I should know about magaldrate?

You should not use this medication if you are allergic to magaldrate.

Before you take magaldrate, tell your doctor if you have kidney disease, Alzheimer's dementia, severe constipation or diarrhea, stomach ulcer or intestinal bleeding, a blockage in your stomach or intestines, or a colostomy or ileostomy.

Do not take this medication for longer than 2 weeks without your doctor's advice. Call your doctor if your symptoms do not improve, or if they get worse while taking magaldrate. This medication can cause you to have unusual results with certain medical tests such as an x-ray, CT scan, or MRI taken using a radioactive dye. Be sure any doctor who treats you knows ahead of time that you are taking magaldrate.

Stop taking magaldrate and call your doctor if you have severe stomach pain or cramps, severe nausea or vomiting, bone pain or muscle weakness, mood changes, or swelling in your hands or feet.

What should I discuss with my health care provider before taking magaldrate?

You should not use this medication if you are allergic to magaldrate.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take magaldrate, tell your doctor if you have:

kidney disease;

Alzheimer's dementia;

severe constipation or diarrhea;

stomach ulcer or intestinal bleeding;

a blockage in your stomach or intestines; or

a colostomy or ileostomy.

FDA pregnancy category C. It is not known whether magaldrate is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Magaldrate may pass into breast milk. Although it is not expected to cause harm to a nursing baby, do not use magaldrate without telling your doctor if you are breast-feeding a baby.

How should I take magaldrate?

Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.

Magaldrate is usually taken 20 to 60 minutes after a meal and at bedtime. Follow your doctor's instructions.

Shake the oral suspension (liquid) well just before you measure a dose. To be sure you get the correct dose, measure the liquid with a marked measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one. Do not take this medication for longer than 2 weeks without your doctor's advice. Call your doctor if your symptoms do not improve, or if they get worse while taking magaldrate. This medication can cause you to have unusual results with certain medical tests such as an x-ray, CT scan, or MRI taken using a radioactive dye. Be sure any doctor who treats you knows ahead of time that you are taking magaldrate. Store magaldrate at room temperature away from moisture and heat. Do not freeze.

See also: Magaldrate dosage (in more detail)

What happens if I miss a dose?

Since magaldrate is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include severe constipation, diarrhea, cramps, or other stomach problems.

What should I avoid while taking magaldrate?

Avoid taking any other medications within 2 hours before or after you take magaldrate. Either magaldrate or the other medications may be less effective when taken at the same time.

Magaldrate side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using magaldrate and call your doctor at once if you have a serious side effect such as:

severe stomach pain, cramps, or bloating;

severe nausea or vomiting;

ongoing loss of appetite, weight loss;

severe constipation;

painful or difficult urination;

bone pain or muscle weakness;

mood changes; or

swelling in your hands or feet.

Less serious side effects may include:

mild constipation or diarrhea;

mild loss of appetite; or

light-colored stools.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Magaldrate Dosing Information

Usual Adult Dose for Dyspepsia:

Dose: 1 to 2 teaspoons after meals and at bedtime

What other drugs will affect magaldrate?

Tell your doctor about all other medications you use, especially:

ursodiol (Actigall, Urso);

ethambutol (Myambutol);

isoniazid;

ketoconazole (Nizoral);

mecamylamine (Inversine);

sodium polystyrene sulfonate (Kayexalate, Kionex);

tacrolimus (Prograf);

vitamin or mineral supplements that contain aluminum, calcium, or iron;

an antibiotic such as ciprofloxacin (Cipro), ofloxacin (Floxin), norfloxacin (Noroxin), levofloxacin (Levaquin), lomefloxacin (Maxaquin), and others;

drugs to treat Paget's disease or osteoporosis, such as alendronate (Fosamax), etidronate (Didronel), ibandronate (Boniva), risedronate (Actonel), or tiludronate (Skelid);

medicines containing phosphates, such as K-Phos, Neutra-Phos, and others;

methenamine (Hiprex, Mandelamine, Urex);

thyroid medications such as levothyroxine (Synthroid) or liothyronine (Cytomel); or

a tetracycline antibiotic such as demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap, Helidac).

This list is not complete and there may be other drugs that can interact with magaldrate. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.

More magaldrate resources

Magaldrate Side Effects (in more detail)
Magaldrate Dosage
Magaldrate Use in Pregnancy & Breastfeeding
Magaldrate Drug Interactions
Magaldrate Support Group
0 Reviews for Magaldrate - Add your own review/rating

Magaldrate Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

Compare magaldrate with other medications

Indigestion

Where can I get more information?

Your pharmacist can provide more information about magaldrate.

See also: magaldrate side effects (in more detail)

Metamucil Orange Coarse Milled Original Texture

What is Metamucil Orange Coarse Milled Original Texture (psyllium)?

Psyllium is a bulk-forming fiber laxative. Psyllium works by absorbing liquid in the intestines and swelling to create a softer, bulky stool that is easier to pass.

Psyllium may also be used for purposes not listed in this product guide.

What is the most important information I should know about Metamucil Orange Coarse Milled Original Texture (psyllium)?

Also talk with your doctor before using psyllium if you have a colostomy or ileostomy, rectal bleeding, or a blockage in your intestines.

What should I discuss with my healthcare provider before taking Metamucil Orange Coarse Milled Original Texture (psyllium)?

trouble swallowing;

a sudden change in bowel habits that lasts longer than 2 weeks;

severe nausea, vomiting, or stomach pain; or

if you have ever had a skin rash while taking psyllium.

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:

a colostomy or ileostomy;

rectal bleeding; or

a blockage in your intestines.

How should I take Metamucil Orange Coarse Milled Original Texture (psyllium)?

Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

The psyllium wafer must be chewed before you swallow it.

Psyllium may be only part of a complete program of treatment that also includes diet, exercise, and weight control. Follow your diet, medication, and exercise routines very closely.

Do not take psyllium for longer than 7 days in a row unless your doctor has told you to. Store at room temperature away from moisture and heat.

What happens if I miss a dose?

Since psyllium is used as needed, it does not have a daily dosing schedule. Call your doctor promptly if your symptoms do not improve after using psyllium.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include nausea, vomiting, and stomach pain. Using a laxative too often or for too long may cause severe medical problems involving your intestines.

What should I avoid while taking Metamucil Orange Coarse Milled Original Texture (psyllium)?

Avoid breathing in the dust from psyllium powder when mixing. Inhaling psyllium dust may cause an allergic reaction.

Metamucil Orange Coarse Milled Original Texture (psyllium) side effects

choking or trouble swallowing;

severe stomach pain, cramping, nausea or vomiting;

constipation that lasts longer than 7 days;

rectal bleeding; or

itchy skin rash.

Less serious side effects may include:

bloating; or

minor change in your bowel habits.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Metamucil Orange Coarse Milled Original Texture (psyllium)?

Tell your doctor about all other medications you use, especially:

a blood thinner such as warfarin (Coumadin, Jantoven); or

demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).

More Metamucil Orange Coarse Milled Original Texture resources

Metamucil Orange Coarse Milled Original Texture Side Effects (in more detail)
Metamucil Orange Coarse Milled Original Texture Use in Pregnancy & Breastfeeding
Metamucil Orange Coarse Milled Original Texture Drug Interactions
0 Reviews for Metamucil Orange Coarse Milled Original Texture - Add your own review/rating

Konsyl Powder MedFacts Consumer Leaflet (Wolters Kluwer)

Metamucil MedFacts Consumer Leaflet (Wolters Kluwer)

Compare Metamucil Orange Coarse Milled Original Texture with other medications

Constipation
Dietary Fiber Supplementation
Irritable Bowel Syndrome

Where can I get more information?

Your pharmacist can provide more information about psyllium.

See also: Metamucil Orange Coarse Milled Original Texture side effects (in more detail)

Tuesday, 27 September 2016

Zonnic

Zonnic may be available in the countries listed below.

Ingredient matches for Zonnic

Nicotine

Nicotine is reported as an ingredient of Zonnic in the following countries:

Sweden

International Drug Name Search

Acide acétique

Acide acétique may be available in the countries listed below.

Ingredient matches for Acide acétique

Acetic Acid

Acide acétique (DCF) is known as Acetic Acid in the US.

International Drug Name Search

Glossary

DCF

Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 28 September 2016

Metamucil Orange Smooth Texture Sugar Free

What is Metamucil Orange Smooth Texture Sugar Free (psyllium)?

What is the most important information I should know about Metamucil Orange Smooth Texture Sugar Free (psyllium)?

What should I discuss with my healthcare provider before taking Metamucil Orange Smooth Texture Sugar Free (psyllium)?

How should I take Metamucil Orange Smooth Texture Sugar Free (psyllium)?

What happens if I miss a dose?

What happens if I overdose?

What should I avoid while taking Metamucil Orange Smooth Texture Sugar Free (psyllium)?

Metamucil Orange Smooth Texture Sugar Free (psyllium) side effects

What other drugs will affect Metamucil Orange Smooth Texture Sugar Free (psyllium)?

More Metamucil Orange Smooth Texture Sugar Free resources

Compare Metamucil Orange Smooth Texture Sugar Free with other medications

Where can I get more information?

halcinonide Topical application

Commonly used brand name(s)

Uses For halcinonide

Before Using halcinonide

Allergies

Pediatric

Geriatric

Interactions with Medicines

Interactions with Food/Tobacco/Alcohol

Other Medical Problems

Proper Use of halcinonide

Dosing

Missed Dose

Storage

Precautions While Using halcinonide

halcinonide Side Effects

More halcinonide Topical application resources

Compare halcinonide Topical application with other medications

Minoxidil topical

Introduction

Uses for Minoxidil

Androgenetic Alopecia

Alopecia Areata

Hair Transplantation

Minoxidil Dosage and Administration

Administration

Topical Administration

Dosage

Adults

Androgenetic Alopecia

Treatment in Men

Treatment in Women

Alopecia Areata†

Topical

Prescribing Limits

Adults

Androgenetic Alopecia

Treatment in Men

Treatment in Women

Special Populations

Cautions for Minoxidil

Contraindications

Warnings/Precautions

General Precautions

Dermatologic Effects

Systemic Effects

Exposure to UV Light

Specific Populations

Pregnancy

Lactation

Pediatric Use

Women

Common Adverse Effects

Interactions for Minoxidil

Topical Preparations

Specific Drugs

Minoxidil Pharmacokinetics

Absorption

Bioavailability

Onset

Distribution

Extent

Elimination

Metabolism

Elimination Route

Stability